The aim of this service is to provide pharmaceutical care to patients receiving treatment for Prostate Cancer, and be proactive in supporting patients to achieve clinical outcomes.
All documents available here:
- A Framework for Locally Enhanced Pharmaceutical Care Services for Patients Receiving Medicines Supervised By Secondary Care
- Community Pharmacy Service: Pharmaceutical Care of Patients Receiving Treatment for Prostate Cancer Service Summary
- Xtandi® (Enzalutamide) NHS Board Service Outline and Governance Checklist
- Zytiga® (Abiraterone) NHS Board Service Outline and Governance Checklist
- Suppliers and Ordering Information for Prostate Cancer treatments
- Prostate Cancer Treatment Service Claim Form
Contractor payment for this service is via NHS AA Service Claim Form.